Back to trial detailsIntake questionnaire
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Applying to Sarcoma Oncology Center · Santa Monica, California
Answer a few short questions to share with the research team.
0 of 3 answered